Disclaimer for US Site Visitors
This web site contains investor-related information that is directed only to non-US persons. The investor-related and other information provided on this web site is for use only by non-U.S persons, and is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any XL TechGroup securities. Moreover, we may not offer or sell XL TechGroup securities in the U.S. absent registration or an exemption from registration. If you are a U.S. person, or a person acquiring XL TechGroup ordinary shares for the account or benefit of any U.S. person, you agree and acknowledge that XL TechGroup's ordinary shares have not been registered under the U.S. Securities Act of 1933, as amended, and any offer or sale of XL TechGroup securities by XL TechGroup or its affiliates may be made solely pursuant to an exemption from the U.S. Securities Act of 1933, as amended.
Welcome/AIM Rules
Welcome to the Investor Relations section of the XL TechGroup web site.
XL TechGroup is a unique value-creation company that works with major corporations to identify significant unmet market needs in the BioTech, EcoTech and MedTech sectors, and then uses a proven, systematic methodology to invent, build, fund, manage and grow to liquidity its own succession of market-changing companies to address these needs.
This area of the web site contains all information which is required to be disclosed in accordance with Rule 26 of the AIM Rules.
In order to be aware of latest news and events as they occur, we also encourage investors to subscribe to our email news alert service.
Investor Relations enquiries
Chris Munden, Director of IR
United Kingdom
Phone +44 (0) 20 7398 7720 | Email cmunden@xltg.com